NCT03917459 - COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 16, 2019

Primary Completion Date

May 25, 2021

Study Completion Date

May 25, 2021

Conditions

Heart FailureHeart Failure, SystolicErectile Dysfunction

Interventions

DRUG

LCZ696

sacubitril/valsartan 200 mg = 97 mg/103 mg bid sacubitril/valsartan film-coated tablets

DRUG

Enalapril matching placebo

Placebo to Enalapril 10 mg film-coated tablets

DRUG

Enalapril

Enalapril 10 mg film-coated tablets

DRUG

LCZ696 matching placebo

Placebo to LCZ696 200 mg = 97 mg/103 mg bid sacubitril/valsartan film-coated tablets

Trial Locations (13)

10367

Novartis Investigative Site, Berlin

10789

Novartis Investigative Site, Berlin

18107

Novartis Investigative Site, Rostock

21244

Novartis Investigative Site, Buchholz in der Nordheide

30159

Novartis Investigative Site, Hanover

39319

Novartis Investigative Site, Jerichow

60594

Novartis Investigative Site, Frankfurt

89077

Novartis Investigative Site, Ulm

90402

Novartis Investigative Site, Nuremberg

96049

Novartis Investigative Site, Bamberg

04564

Novartis Investigative Site, Böhlen

04416

Novartis Investigative Site, Markkleeberg

04779

Novartis Investigative Site, Wermsdorf